darunavir has been researched along with rifapentine in 2 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (rifapentine) | Trials (rifapentine) | Recent Studies (post-2010) (rifapentine) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 404 | 77 | 242 |
| Protein | Taxonomy | darunavir (IC50) | rifapentine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 9.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adeojo, L; Brooks, KM; Bunn, HT; George, JM; Kovacs, JA; Kumar, P; Pau, AK; Peloquin, CA; Swaim, D | 1 |
1 review(s) available for darunavir and rifapentine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for darunavir and rifapentine
| Article | Year |
|---|---|
Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine.
Topics: Cobicistat; Cross-Over Studies; Darunavir; Drug Combinations; HIV Infections; Humans; Isoniazid | 2023 |